Trial Profile
Randomized, double-blind, placebo-controlled, multicentre, parallel-group study of Futagliptin benzoic acid in T2DM
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2018
Price :
$35
*
At a glance
- Drugs Fotagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Aug 2018 New trial record